Ollin Biosciences has completed an oversubscribed
Author: Michael
Circulate Health and Reborne announced an exclusi
The health optimization company opens its larges
Wellthspan Advisory’s Nadine Esposito explains
Leal Therapeutics has dosed the first participant
AnHorn Medicines announced in Taipei that its lea
AnHorn Medicines announced in Taipei that its lea
Rapalogix Health said it closed a $20 million Ser
New deal-by-deal syndicate is backing founders i
AcCELLerated Biologics and Forever Labs team up